FDA to require vision loss warning on GLP-1 drug labels
GLP-1 drugs such as Ozempic and Wegovy prescribed in the U.S. will contain a new warning about a possible but rare side effect that can lead to permanent vision loss, the Food and Drug Administration (FDA) announced Monday. The FDA will require the risk to …